Sources tell CNBC the plan would let pharmacies temporarily compound popular peptides like BPC-157, despite FDA staff safety concerns.
Recap by typeshit. Full story at CNBC.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
A brief post suggests cases from other countries could hint at how serious unapproved drug use might get in the US, with a link to international reports.
An August 2025 ruling sided with Novo Nordisk and Lilly. Plaintiffs need an accepted test, not just symptoms or records, and testing after stopping the drug can complicate a claim.
Loading…